伟思医疗: 南京伟思医疗科技股份有限公司第四届监事会第四次会议决议公告

Meeting Overview - The fourth meeting of the fourth Supervisory Board of Nanjing Weisi Medical Technology Co., Ltd. was held on June 27, 2025, in a combined onsite and communication format [1][2] - All three supervisors attended the meeting, which complied with relevant laws and regulations [1][2] Resolutions Passed Adjustment of Stock Incentive Plan - The Supervisory Board approved the adjustment of the list of initial grant recipients and the number of shares for the 2025 Restricted Stock Incentive Plan, reducing the number of recipients from 74 to 71 and the number of shares from 904,000 to 872,000 [2][3] - The total number of restricted shares to be granted was adjusted from 1,000,000 to 968,000, with a reserve of 96,000 shares remaining unchanged [2][3] Granting of Restricted Stock - The Supervisory Board confirmed that the conditions for granting restricted stock to the incentive recipients had been met, approving the grant of 872,000 shares at a price of 22 yuan per share to 71 recipients on June 27, 2025 [4][5] Use of Own Funds for Project Financing - The Supervisory Board approved the use of the company's own funds to pay for personnel costs related to fundraising projects, with plans to replace these funds with equivalent amounts from raised funds later [5]